NDC 71872-7192-01 - Clindamycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7192
- Requested NDC
- 71872-7192-01
- Package NDCs from labels
- 71872-7192-1, 71872-7192-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2023-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7192-1 | Clindamycin | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 2 | |
| 71872-7192-1 | Clindamycin | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7192 | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20230511_9e500a08-0339-eb6b-e053-2a95a90a130c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XACIATO | CLINDAMYCIN PHOSPHATE | Organon LLC | 0423007f-28fa-4159-bf58-9174626d2347 | 2026-02-19 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Henry Schein, Inc. | 8a4e2ba4-90e6-48e8-a943-0c5d3f169780 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | ANDA090108 1737578 EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE USP, 1% | A-S Medication Solutions | 193a4b02-910f-46b2-8b61-25efea694720 | 2026-02-02 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin and benzoyl peroxide | CLINDAMYCIN AND BENZOYL PEROXIDE | Glenmark Pharmaceuticals Inc., USA | 76795d1b-e1f2-4d1d-b42a-f1d4448c63c0 | 2026-01-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d0ec3e88-40d9-4919-afc3-cf2e7e863376 | 2026-01-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 997a23c8-f0d7-49d5-af33-e11f2ddab3c7 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d36bad26-f337-4a71-a6e5-d97b60f4e385 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 62a2019f-7410-4251-95ed-181925ade6e4 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Sun Pharmaceutical Industries, Inc. | 80c40d1a-2541-4164-8ccb-1b512a851734 | 2026-01-25 | Warnings, Adverse reactions | EH6D7113I8 |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Abdominal Pain Drops 2051 | ABDOMINAL PAIN DROPS | Professional Complementary Health Formulas | f1b1dde6-bb37-4774-a58c-b4f648f9c2b5 | 2026-01-08 | Warnings | QTT17582CB |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Viona Pharmaceuticals Inc | 585e8b72-b350-451f-a232-199b1a01e8ce | 2026-01-07 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Encube Ethicals, Inc. | ba6ae5da-affa-422b-9a53-28f3fc001523 | 2026-01-06 | Warnings, Adverse reactions | EH6D7113I8 |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE TOPICAL | Carnegie Pharmaceuticals, LLC | c8fe61f1-f3c5-4452-9980-a727461b9844 | 2025-12-15 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Mylan Pharmaceuticals Inc. | f7480256-8b32-419a-8983-e2c413040dba | 2025-12-12 | Warnings, Adverse reactions | EH6D7113I8 |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Alembic Pharmaceuticals Inc. | 96434354-a646-4869-92a2-4052d3f7a4aa | 2025-12-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | e492d645-7d2e-4f8a-a43a-9999456e9f72 | 2025-11-30 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.